Increased mRNA expression of collagen v gene in pulmonary fibrosis of systemic sclerosis

European Journal of Clinical Investigation

Volumn 40, Issue 2, 2010, Pages 110-120

  Parra, E R ^a   Teodoro, W R ^a   De Morais, J ^a   Katayama, M L H ^a   De Souza, R ^a   Yoshinari, N H ^a   Capelozzi, V L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Collagen V; Molecular biology; Systemic sclerosis; Three dimensional reconstruction

Indexed keywords

CARBON MONOXIDE; COLLAGEN FIBER; COLLAGEN TYPE 5; MESSENGER RNA;

ACINAR CELL; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INJURY; LUNG ALVEOLUS WALL; LUNG BIOPSY; LUNG DEPOSIT; LUNG PARENCHYMA; MALE; MORPHOMETRICS; PRIORITY JOURNAL; PROTEIN CONTENT; REAL TIME POLYMERASE CHAIN REACTION; SYSTEMIC SCLEROSIS; THREE DIMENSIONAL IMAGING; VITAL CAPACITY;

ADULT; BIOPSY; COLLAGEN; FEMALE; FLUOROIMMUNOASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; POLYMERASE CHAIN REACTION; PULMONARY FIBROSIS; RNA, MESSENGER; SCLERODERMA, SYSTEMIC;

EID: 75149141884     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02224.x     Document Type: Article

References (40)

1. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009 360 : 1989 2003.
2. Tan FK. Systemic sclerosis: the susceptible host genetics and environment. Rheum Dis Clin North Am 2003 29 : 211 237.
3. LeRoy EC. Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 1974 54 : 880 889.
4. Vuorio TK, Kahari VM, Lehtonen A, Vuorio EI. Fibroblast activation in scleroderma. Scand J Rheumatol 1984 13 : 229 237.
5. Kähäri VM, Sandberg M, Kalimo H, Vuorio TK, Vuorio EI. Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. J Invest Dermatol 1988 90 : 664 670.
6. Scharffetter K, Lankat-Buttgereit B, Krieg T. Localization of collagen mRNA in normal and scleroderma skin by in situ hybridization. Eur J Clin Invest 1988 18 : 9 17.
7. Needleman BW. Increased expression of intercellular adhesion molecule 1 on the fibroblasts of scleroderma patients. Arthritis Rheum 1990 33 : 1847 1851.
8. Kawaguchi Y. IL-1 a gene expression and protein production by fibroblasts from patients with systemic sclerosis. Clin Exp Immunol 1994 97 : 445 450.
9. Feghali CA, Bost KL, Boulware DW, Levy LS. Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol 1992 19 : 1207 1211.
10. Sollberg S, Peltonen J, Uitto J, Jimenez SA. Elevated expression of b 1 and b 2 integrins, intercellular adhesion molecule 1, and endo-thelial leukocyte adhesion molecule 1 in the skin of patients with systemic sclerosis of recent onset. Arthritis Rheum 1992 35 : 290 298.
11. Kahaleh MB. The vascular endothelium in scleroderma. Int Ver Immunol 1995 12 : 227 245.
12. Teodoro WR, Velosa AP, Witzel SS, Garippo AL, Farhat C, Parra ER et al. Architectural remodelling in lungs of rabbits induced by type V collagen immunization: a preliminary morphologic model to study diffuse connective tissue diseases. Pathol Res Pract 2004 200 : 681 691.
13. Bezerra MC, Teodoro WR, de Oliveira CC, Velosa AP, Ogido LT, Gauditano G et al. Scleroderma-like remodeling induced by type V collagen. Arch Dermatol Res 2006 298 : 51 7.
14. Callado MR, Viana VS, Vendramini MB, Leon EP, Bueno C, Velosa AP et al. Autoantibody profile in the experimental model of scleroderma induced by type V human collagen. Immunology 2007 122 : 38 46.
15. Mayne R, Burgeson R. Structure and function of collagen types. In : Ulecham R, editor. Biology of extracellular matrix. 20th ed. London : Academic Press 1993. p. 1 37.
16. Fichard A, Kleman JP, Ruggiero F. Another look at collagen V and XI molecules. Matrix Biol 1995 14 : 515 531.
17. Fichard A, Tillet E, Delacoux F, Garrone R, Ruggiero F. Human recombinant α1(V) collagen chain. Homotrimeric assembly and subsequent processing. J Biol Chem 1997 272 : 30083 3008711.
18. Birk DE. Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron 2001 32 : 223 237.
19. Parra ER, Aguiar AC Jr., Gonçalves R, Teodoro WR, de Souza WTA, Yoshinari NH et al. Vascular injury and abnormal type V collagen deposition promote functional and architectural alteration in pulmonary systemic sclerosis. Histopathology 2008 : 53 : 357 (Abstract).
20. Martin P, Teodoro W, Braga F, Carrasco S, Velosa A, Souza R et al. Collagen V fibers in scleroderma skin plaque: elevated expression and abnormal distribution by electron microscopy, culture and immunofluorescencia. Histophatology 2008 53 : 395 Abstract).
21. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980 23 : 581 590.
22. American Heart Association. 1994 revisions to classification of functional capacity and objective assessment of patients with diseases of the heart. Available at: http://www.americanheart.orghttp://www.americanheart.org. Accessed July 18, 2009
23. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr. et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988 15 : 202 205.
24. American Thoracic Society/European Respiratory Society. International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonia. Am J Respir Crit Care Med 2002 165 : 277 304.
25. Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002 165 : 1581 1586.
26. Wechsler RJ, Steiner RM, Spirn PW, Rubin S, Salazar AM, Shah R et al. The relationship of thoracic lymphadenopathy to pulmonary interstitial disease in diffuse and limited systemic sclerosis: CT findings. AJR Am J Roentgenol 1996 167 : 101 104.
27. Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Lung volumes and forced ventilatory flows. Report working party, Standardization of lung function tests, European Community for steel and coal. Official Statement of the European respiratory Society. Eur Respir J 1993 16 : 5 40.
28. Blumer R, Konakci KZ, Brugger PC, Blumer MJ, Moser D, Schoefer C et al. Muscle spindles and Golgi tendon organs in bovine calf extraocular muscle studied by means of double-fluorescent labeling, electron microscopy, and three-dimensional reconstruction. Exp Eye Res 2003 77 : 447 462.
29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C(T)] Method. Methods 2001 25 : 402 408.
30. de Carvalho EF, Parra ER, de Souza R, A'b Saber AM, Machado Jde C, Capelozzi VL. Arterial and interstitial remodelling processes in non-specific interstitial pneumonia: systemic sclerosis versus idiopathic. Histopathology 2008 53 : 195 204.
31. Roulet M, Ruggiero F, Karsenty G. A comprehensive study of the spatial and temporal expression of the col5a1 gene in mouse embryos: a clue for understanding collagen V function in developing connective tissues. Cell Tissue Res 2007 327 : 323 332.
32. van der Rest M, Dublet B, Champliaud MF. Fibril-associated collagens. Biomaterials 1990 11 : 28 31.
33. Myllyharju J, Kivirikko KI. Collagens and collagen-related diseases. Ann Med 2001 33 : 7 21.
34. Liu T, Zhang J. Expression and distribution of type I, III and V collagens in skin lesions from patients with systemic sclerosis. Sichuan Da Xue Xue Bao Yi Xue Ban 2008 39 : 748 752 (Abstract).
35. Liu T, Zhang J. Detection of V, III and I type collagens of dermal tissues in skin lesions of patients with systemic sclerosis and its implication. J Huazhong Univ Sci Technolog Med Sci 2008 28 : 599 603.
36. Shahzeidi S, Jefery PK, Laurent McAnulty RJ. Increased type I procollagen mRNA transcripts in the lung of mice during the development of bleomycin-induced fibrosis. Eur Respir J 1994 7 : 1938 1943.
37. Kenyon NJ, Ward RW, McGrew G, Last JA. TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice. Thorax 2003 58 : 772 777.
38. Schwarze U, Atkinson M, Hoffman GG, Greenspan DS, Byers PH. Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II). Am J Hum Genet 2000 66 : 1757 1765.
39. Wenstrup RJ, Langland GT, Willing MC, D'Souza VN, Cole WGA. splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of proa1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I). Hum Mol Genet 1996 5 : 1733 1736.
40. Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TG, Connolly MK et al. Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One 2008 16 : e2696.